Asheville-based start-up using AI to control glucose in the critical care space
An Asheville-based start-up that is using artificial intelligence (AI) to control glucose in the critical care space has raised $200,000 in debt, according to this article in WRAL TechWire. The company – Ideal Medical Technologies – is developing an AI-based artificial pancreas system called FUSION. It uses software that adjusts the doses of intravenous insulin/glucose infusing into the patients on a five- to 10-minute basis.
Like what you've read?
Forward to a friend!